The Government continues to review the evolving national security risks in the life sciences sector, including engaging with partners and allies, while ensuring that the United Kingdom is at the forefront of innovation.

The Procurement Act will come into force in 2025 and will include a Debarment Review Service, which aims to safeguard public procurement from suppliers deemed to pose a risk. As with all national security risks, there will be engagement with colleagues across Cabinet and Parliament to ensure we maintain a robust approach to managing these risks as they evolve.

Through the delivery of the UK Biological Security Strategy, the Government is committed to ensuring the United Kingdom is resilient to a spectrum of biological threats, as well as being a world leader in innovation. As part of this strategy, the Government is undertaking a programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy and build confidence in sharing personal data, to improve health outcomes in the UK and across the world.

Department officials are working closely with UK Biobank, Genomics England, and the National Institute for Health and Care Research Bioresource on this programme of work, and there will be continued engagement with my Cabinet colleagues.

Through the delivery of our Biological Security Strategy, the Government is committed ensuring the UK is resilient to a spectrum of biological threats, as well as being a world leader in innovation. As part of this Strategy, the Government is undertaking a programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy and build confidence in sharing personal data to improve health outcomes in the UK and across the world. This review covers the extent to which the UK shares data with certain companies.

Currently, organisations which hold sensitive biological data are subject to the UK General Data Protection Regulation (GDPR). In addition, organisations such as Genomics England, UK Biobank and NIHR BioResource actively consider national security in decision making about partnerships with companies overseas. These organisations consult with security personnel on a regular basis to ensure partnerships are aligned with our national security interests.

Organisations which hold sensitive biological data are subject to the UK General Data Protection Regulation (GDPR). In addition, organisations such as Genomics England, UK Biobank and NIHR BioResource actively consider national security in decision making about partnerships with companies overseas.

As part of the new UK Biological Security Strategy, the Government is undertaking a programme of work to assess how we can minimise the risks from biological data to protect our burgeoning bioeconomy, without stifling innovation, and build confidence in sharing personal data to improve health outcomes in the UK and across the world. The Office for Life Sciences has begun this work, in consultation with relevant Departments and Agencies across Government, and key partners such as Genomics England and UK Biobank.